Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Lucianito77
    Junior Member
    • Jul 2015
    • 4

    #1

    On/Off target cfDNA targeted sequencing

    Dear all,

    I hope this email finds you well.

    I prepared cfDNA libraries using ThruPlex TagSeq (Rubicon) starting with 25 ng cfDNA measured using Qbit. In parallel I also prepared similar liberties using matched normal gDNA sheared to 150-200 bp. I captured these libraries using an Agilent custom panel of 0.47 Mb following Rubicon’s instructions (5 cycles PCR). For post-capture I used 16 cycles PCR (as suggested for panels 1 kb-0.5 Mb). Libraries look good after capture (see example attached)

    To be able to run downsampling experiments to determine the amount of sequencing required to obtain a given duplication rate, or to obtain a given family size I sequenced cfDNA samples so that I obtained 110-125 million PE 2x75 reads (220-250 million reads) and 20 million PE 2x75 reads (40 million reads) using NextSeq500 high output.

    (Note: I analysed the samples using Curio software (specialized to analyze data from TagSeq), by aligning with BWA-MEM and selecting for UMI containing reads.)

    When I analysed the coverage I was surprised to see that while the off-target (as judged by the high number of reads on untargeted regions) was much higher in the cfDNA sample than in the normal sample, the duplication rate (which i expected to be higher) was not incremented whatsoever and, moreover, the family size was actually lower than in normal. I fund this extremely odd. The coverage analysis indicated that ~2.5 million families were formed in both samples.

    My question, how can it be that the off target soared without increasing the duplication rate nor the family size?

    Any help will be appreciated.

    Luciano
    Lucianito77 is online now Report Post
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...